User:Iluvicedtea/sandbox

Emily Ying Chew , M.D., is an ophthalmologist and an expert on the human retina with a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She currently works for the National Eye Institute (NEI) at the National Institutes of Health (NIH) in Bethesda, Maryland where she serves as deputy director of the Division of Epidemiology and Clinical Applications (DECA) and the Institute’s deputy clinical director. She designs and implements Phase 1, 2 and 3 clinical trials at the NIH Clinical Center. Dr. Chew is board certified in ophthalmology.

Education
Dr. Ostrander received her B.S. degree from the University of Washington in Seattle. In 1987, she was awarded a Ph.D. from the Oregon Health Sciences University in Portland. She completed postdoctoral training in molecular biology at Harvard. From 1991-1993, she was a staff scientist in the Genetics and Human Genome Project at Lawrence Berkeley National Laboratory in Berkeley, California. At Berkeley, she worked in the laboratory of Jasper Rine, where the dog genome project originated.

Career
Dr. Ostrander received her Ph.D. from the Oregon Health Sciences University in Portland, Oregon and did her postdoctoral training at Harvard University in Cambridge, Massachusetts. She then went to University of California, Berkeley and the Lawrence Berkeley National Labs. There, with collaborators, she began the canine genome project and built the canine linkage and radiation hybrid maps. Dr. Ostrander also held academic appointments at the Fred Hutchinson Cancer Research Center in Seattle, Washington and the University of Washington for 12 years, where she rose to the rank of member in the Human Biology and Clinical Research Divisions and head of the Genetics Program.

She came to the NIH in 2004. At NHGRI, she holds a number of professional academic appointments, serving as senior scientist and head of the Section of Comparative Genetics; Chief of the Cancer Genetics Branch; and Chief of the Cancer Genetics and Comparative Genomics Branch. She is also an NHGRI grant recipient.

Dr. Ostrander has served on the faculty of a number of leading biomedical research institutions, including the Fred Hutchinson Cancer Research Center in Seattle, Washington; the University of Washington in Seattle, and NHGRI in Bethesda, Maryland. She is also affiliated as a mentor in the human genetics predoctoral training program at the Johns Hopkins University School of Medicine in Baltimore. Her professional academic responsibilities continue to extend into a number of leadership roles in planning, search, peer review, and tenure and promotion efforts at a number of scientific institutions, including NHGRI; the Johns Hopkins University School of Medicine; the Fred Hutchinson Cancer Research Center in Seattle, Washington; the U.S. Department of Defense (various). At present, she also oversees admissions for the NIH-Graduate/Cambridge Program.

The NHGRI Dog Genome Project
Ostrander's lab is examining


 * add pictures from NHGRI's website on project

Honors
Dr. Ostrander has presented her research at national and international scientific meetings. In 2011, she was named NIH Distinguished Investigator. She is the author of nearly 300 scientific publications that have been cited more than 3,500 times, including more than 450 citations to the 2005 paper she co-authored describing the genome sequence of the domestic dog.

In 1999, Dr. Ostrander was awarded the President’s Award by the American Kennel Club Canine Health Foundation, followed by the AKC Canine Health Foundation Asa Mays Award for Excellence in Canine Health Research (2005), and the Lifetime Achievement canine health award presented by the Kennel Club in 2013. She is also the recipient of the Burroughs Wellcome Fund Innovation Award in Functional Genomics and the Lifetime Achievement Award from Weill Cornell Medical College’s Prostate Cancer Institute.

She has also served in an advisory capacity on behalf of leading professional societies, journals, and other scientific efforts in the United States, Belgium, Sweden, and elsewhere. Dr. Ostrander is a member of the American Association for the Advancement of Science (AAAS) and in 2013, was inducted as a Fellow. She is a member of the American Society of Human Genetics, the American Genetic Association, the American Association for Cancer Research, Women in Cancer Research, the Genetics Society of America, and the Association for Women in Science. Dr. Ostrander served a term on the Board of Directors of the American Society of Human Genetics and in 2013 received the Genetics Society of America medal.

Patents
Dr. Ostrander holds two U.S. patents: Application 20100217534 Patent Number (20110224911) and Application 200901762555, both related to genetic identification of dog breeds.

Key Publications
http://irp.nih.gov/pi/elaine-ostrander